Aetna Health Plans has joined the growing list of private insurancecompanies that have authorized reimbursement of positron emissiontomography scans. Aetna began covering PET scans early this year after the company'stechnology review board last winter
Aetna Health Plans has joined the growing list of private insurancecompanies that have authorized reimbursement of positron emissiontomography scans.
Aetna began covering PET scans early this year after the company'stechnology review board last winter recommended use of the modalityfor three applications, according to William McGivney, head oftechnology assessment for the insurer.
Blue Cross/Blue Shield (BC/BS) issued a similar endorsementof PET in July (SCAN 8/12/92). PET supporters hope that privatethird-party reimbursement will snowball as a federal decisionapproaches on Medicare reimbursement for PET.
Aetna's authorization includes two neurological applicationsrecommended by BC/BS, but it also covers cardiac PET, which wasnot recommended by BC/BS. This will help overcome the perceptionthat cardiac PET is still an experimental procedure, accordingto Michael McGehee of the Institute for Clinical PET in Washington,DC.
"The importance to us is the cardiac component of it,"McGehee said. "That firmly establishes that a national firmis going to be paying for cardiac scans. That's a significantperceptual point."
Aetna reimburses PET as follows:
Aetna's decision is also important because it applies to allhealth plan policyholders. The national BC/BS endorsement wasnot binding on individual BC/BS affiliates, although most affiliatesabide by the national office's recommendations.
McGehee expects the Health Care Financing Administration tomake a decision on Medicare PET reimbursement toward the middleof next year. If PET gets the green light, a decision on reimbursementrates will also be made at that time. The ICP has been gatheringinformation on scan charges at PET sites across the country andwill present the data to HCFA to help the agency draw up a reimbursementschedule, McGehee said.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.